SCOPUS 정보 검색 플랫폼

Seminars in Hematology

Volumn 38, Issue 3, 2001, Pages 203-208

Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience

(3) Crowley, John a,b Jacobson, Joth a,b Alexanian, Ray a,b

a SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER (United States)

b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LEVAMISOLE; MELPHALAN; PREDNISONE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DATA ANALYSIS; DOSE RESPONSE; DRUG MEGADOSE; EXPERIENCE; HUMAN; MAINTENANCE THERAPY; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVIEW;

EID: 0034891847 PISSN: 00371963 EISSN: None Source Type: Journal
DOI: 10.1016/S0037-1963(01)90011-3 Document Type: Article

Times cited : (16)

References (20)

1
- 0016774995
- Prognostic factors in multiple myeloma
- (1975) Cancer , vol.36 , pp. 1192-1201
- Alexanian, R.¹ Balcerzak, S.² Bonnet, J.³

2
- 0017709931
- Combination therapy for multiple myeloma
- (1977) Cancer , vol.40 , pp. 2765-2771
- Alexanian, R.¹ Salmon, S.² Bonnet, J.³

3
- 0017858491
- Unmaintained remissions in multiple myeloma
- (1978) Blood , vol.51 , pp. 1005-1011
- Alexanian, R.¹ Gehan, E.² Haut, A.³

4
- 0019475513
- Chemoimmunotherapy for multiple myeloma
- (1981) Cancer , vol.47 , pp. 1923-1929
- Alexanian, R.¹ Salmon, S.² Gutterman, J.³

5
- 0021352373
- Chemotherapy for multiple myeloma
- (1984) Cancer , vol.53 , pp. 583-588
- Alexanian, R.¹ Dreicer, R.²

6
- 0030053014
- Whither interferon for myeloma and other hematologic malignancies?
- (1996) Ann Intern Med , vol.124 , pp. 264-265
- Alexanian, R.¹ Weber, D.²

7
- 0026570466
- Intensive combined therapy for previously untreated aggressive myeloma
- (1992) Blood , vol.79 , pp. 1130-1136
- Attal, M.¹ Huguet, F.² Schlaifer, D.³

8
- 0021322023
- Effective treatment of advanced multiple myeloma refractory to alkylating agents
- (1984) N Engl J Med , vol.310 , pp. 1353-1356
- Barlogie, B.¹ Smith, L.² Alexanian, R.³

9
- 0026099489
- Multiple myeloma: VMCP/VBAP is not superior to melphalan and prednisone even in high risk patients
- (1991) J Clin Oncol , vol.9 , pp. 444-448
- Boccadoro, M.¹ Marmont, F.² Tribalto, M.³

10
- 0002247546
- Exploratory methods in survival analysis
- (1995) IMS Lecture Notes , vol.27 , pp. 55-77
- Crowley, J.¹ Leblanc, M.² Gentleman, R.³

11
- 0002946165
- Some exploratory tools for survival analysis
- Seattle, WA, 1997
- (1997) Lecture Notes In Statistics. Proceedings of the First Seattle Symposium in Biostatistics: Survival Analysis , pp. 199-229
- Crowley, J.¹ LeBlanc, M.² Jacobson, J.³

12
- 0016804136
- A clinical staging system for multiple myeloma
- (1975) Cancer , vol.36 , pp. 842-854
- Durie, B.G.M.¹ Salmon, S.E.²

13
- 0022922110
- Improved survival duration with combination chemotherapy induction for multiple myeloma: A Southwest Oncology Group study
- (1986) J Clin Oncol , vol.4 , pp. 1227-1237
- Durie, B.G.M.¹ Dixon, D.O.² Carter, S.³

14
- 0025178669
- 2 microglobulin in myeloma: A Southwest Oncology Group study
- (1990) Blood , vol.75 , pp. 823-830
- Durie, B.G.M.¹ Stock-Novack, D.² Salmon, S.E.³

15
- 0004090036
- Los Angeles, CA, The International Myeloma Foundation
- (1996) Multiple Myeloma: A Concise Review of the Disease and Treatment Options
- Durie, B.G.M.¹

16
- 0019952884
- Rationale for the use of alternating non-cross-resistant chemotherapy
- (1982) Cancer Treat Rep , vol.66 , pp. 439-449
- Goldie, J.H.¹ Coldman, A.J.² Gudauskas, G.A.³

17
- 0026337620
- Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: A Southwest Oncology Group study
- (1991) Blood , vol.78 , pp. 3281-3287
- Saeed, S.M.¹ Stock-Novack, D.² Pohlod, R.³

18
- 0025078906
- Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: A Southwest Oncology Group study
- (1990) J Clin Oncol , vol.8 , pp. 1575-1584
- Salmon, S.E.¹ Tesh, D.² Crowley, J.³

19
- 0028075566
- Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: A Southwest Oncology Group study
- (1994) J Clin Oncol , vol.12 , pp. 2405-2414
- Salmon, S.E.¹ Crowley, J.J.² Grogan, T.M.³

20
- 0031934633
- Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: A Southwest Oncology Group study
- (1998) J Clin Oncol , vol.16 , pp. 890-896
- Salmon, S.E.¹ Crowley, J.J.² Balcerzak, S.P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.